Published in World J Gastrointest Oncol on September 15, 2015
Increased Plasma Levels of Chemoresistance-Inducing Fatty Acid 16:4(n-3) After Consumption of Fish and Fish Oil. JAMA Oncol (2015) 2.65
High rates of resolution of cholestasis in parenteral nutrition-associated liver disease with fish oil-based lipid emulsion monotherapy. J Pediatr (2012) 1.14
Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease. Inflamm Bowel Dis (2009) 1.08
The potential utility of telomere-related markers for cancer diagnosis. J Cell Mol Med (2011) 1.04
Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease. Nutrients (2013) 0.93
Impact of fish oil enriched total parenteral nutrition on elderly patients after colorectal cancer surgery. Chin Med J (Engl) (2012) 0.90
Superiority of a fish oil-enriched emulsion to medium-chain triacylglycerols/long-chain triacylglycerols in gastrointestinal surgery patients: a randomized clinical trial. Nutrition (2011) 0.89
Telomere shortening in elderly individuals with mild cognitive impairment may be attenuated with ω-3 fatty acid supplementation: a randomized controlled pilot study. Nutrition (2013) 0.88
Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acids. Nutr Rev (2013) 0.86
Fish oil-based lipid emulsions in the treatment of parenteral nutrition-associated liver disease: an ongoing positive experience. Adv Nutr (2014) 0.86
Parenteral fish oil as a pharmacological agent to modulate post-operative immune response: a randomized, double-blind, and controlled clinical trial in patients with gastrointestinal cancer. Clin Nutr (2012) 0.86
A randomised study on the clinical progress of high-risk elective major gastrointestinal surgery patients treated with olive oil-based parenteral nutrition with or without a fish oil supplement. Br J Nutr (2010) 0.85
Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk. Dig Dis (2014) 0.85
Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease. Adv Nutr (2014) 0.85
Prevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptor. Anticancer Agents Med Chem (2012) 0.84
Linking immunity, epigenetics, and cancer in inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.82
Nutrigenetics, nutrigenomics and inflammatory bowel diseases. Expert Rev Clin Immunol (2013) 0.82
Fatty acids, lipid emulsions and the immune and inflammatory systems. World Rev Nutr Diet (2014) 0.82
Combining nutrition, food science and engineering in developing solutions to Inflammatory bowel diseases--omega-3 polyunsaturated fatty acids as an example. Food Funct (2010) 0.81
Lipids for intravenous nutrition in hospitalised adult patients: a multiple choice of options. Proc Nutr Soc (2013) 0.81
A double-blind randomized study comparing the efficacy and safety of a composite vs a conventional intravenous fat emulsion in postsurgical gastrointestinal tumor patients. Nutr Clin Pract (2012) 0.80
Effects on varying intravenous lipid emulsions on the small bowel epithelium in a mouse model of parenteral nutrition. JPEN J Parenter Enteral Nutr (2013) 0.80
Successful treatment of parenteral nutrition-associated liver disease in an adult by use of a fish oil-based lipid source. Nutrition (2012) 0.80
The role of total parenteral nutrition in inflammatory bowel disease: current aspects. Scand J Gastroenterol (2014) 0.79
Short-term intravenous fish-oil emulsions in pediatric oncologic patients--effect on liver parameters. Nutr Cancer (2014) 0.78
Successful treatment of parenteral nutrition-associated liver disease in an adult by use of a fish oil-based lipid source. Nutrition (2013) 0.77
Nutrition support in the intensive care patient. J Infus Nurs (2013) 0.77